World's Best Scientists 2026 revealed!
Øystein Fodstad

Øystein Fodstad

D-Index & Metrics

Medicine

D-Index
87
Citations
28495
World Ranking
13623
National Ranking
62

Øystein Fodstad publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Øystein Fodstad sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 381 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Øystein Fodstad D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Øystein Fodstad sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Øystein Fodstad is affiliated with Oslo University Hospital in Norway and has contributed significantly to the fields of medicine, biochemistry, genetics, and molecular biology. Their research spans several specialized subfields such as pulmonary and respiratory medicine, oncology, molecular biology, cancer research, and immunology.

The research topics Øystein Fodstad focuses on include:

  • Cancer Immunotherapy and Biomarkers
  • Renal cell carcinoma treatment
  • Cancer, Hypoxia, and Metabolism
  • Immunotherapy and Immune Responses
  • Prostate Cancer Treatment and Research
  • Immune Cell Function and Interaction
  • Renal and related cancers

Recent papers authored or co-authored by Øystein Fodstad cover a range of important topics in cancer research and immune checkpoint studies. These include:

  • "New frontiers in immune checkpoint B7-H3 (CD276) research and drug development," 2023, published in Molecular Cancer
  • "Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma," 2020, published in Annals of Diagnostic Pathology
  • "Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer," 2021, published in The Prostate
  • "Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer," 2022, published in Pathology - Research and Practice
  • "Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy," 2021, published in Annals of Surgical Oncology

Øystein Fodstad frequently publishes in venues such as Scientific Reports, Molecular Cancer, Annals of Diagnostic Pathology, The Prostate, and Pathology - Research and Practice.

Frequent collaborators of Øystein Fodstad include:

  • Gunhild M. Mælandsmo
  • Caroline E. Nunes-Xavier
  • Roberto Llarena
  • Rafael Pulido
  • José I. López

Their work often intersects with studies on immune checkpoint proteins, androgen receptors, and cancer prognostics. Research by Øystein Fodstad addresses critical areas in cancer immunotherapy, renal and prostate cancer treatment, and the molecular mechanisms underlying these diseases.

Best Publications

  • Tumour exosome integrins determine organotropic metastasis

    Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues

  • Detection and clinical importance of micrometastatic disease

    Klaus Pantel;Richard J. Cote;Øystein Fodstad

  • The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

    Adam I Riker;Steven A Enkemann;Oystein Fodstad;Suhu Liu

  • Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.

    Kristian Berg;Pål Kristian Selbo;Lina Prasmickaite;Torunn E. Tjelle

  • Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition

    Marc F. Hansen;Alex Koufos;Brenda L. Gallie;Robert A. Phillips

  • MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression

    Ming Zhou;Ming Zhou;Zixing Liu;Yuhua Zhao;Yan Ding

  • Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

    Bo Song;Yuan Wang;Yuan Wang;Yaguang Xi;Kenji Kudo

  • Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol

    Ming-Ming Zhou;Ming-Ming Zhou;Yuhua Zhao;Yan Ding;Hao Liu

  • Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

    E. Borgen;B. Naume;J.M. Nesland;G. Kvalheim

  • Significant Antitumor Effect from Bone-seeking, α-Particle-emitting 223Ra Demonstrated in an Experimental Skeletal Metastases Model

    Gjermund Henriksen;Knut Breistøl;Øyvind S. Bruland;Øystein Fodstad

  • Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

    Yuhua Zhao;Hao Liu;Zixing Liu;Yan Ding

  • The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma

    Germana Rappa;Oystein Fodstad;Aurelio Lorico

  • Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth

    Y. H. Zhao;M. Zhou;H. Liu;Y. Ding

  • Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer

    Yaguang Xi;Reut Shalgi;Oystein Fodstad;Yitzhak Pilpel

  • Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

    Vivi Ann Flørenes;Steinar Aamdal;Ola Myklebost;Gunhild M. Maelandsmo

  • Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma

    Gunhild Mari Maelandsmo;Vivi Ann Flørenes;Turid Mellingsaeter;Eivind Hovig

  • MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status

    Vivi Ann Flørenes;Gunhild Mari Mælandsmo;Anne Forus;Åshild Andreassen

  • Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells

    Paal Ruud;Øystein Fodstad;Eivind Hovig

  • S100A4 Involvement in Metastasis Deregulation of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Osteosarcoma Cells Transfected with an Anti-S100A4 Ribozyme

    Kristin Bjørnland;Jan Olof Winberg;Olav Tobias Ødegaard;Eivind Hovig

  • REVIEW Detection and Clinical Importance of Micrometastatic Disease

    Klaus Pantel;Richard J. Cote;Øystein Fodstad

Frequent Co-Authors

Gunnar Kvalheim
Gunnar Kvalheim Oslo University Hospital
Alexander Pihl
Alexander Pihl University of Oslo
Jahn M. Nesland
Jahn M. Nesland Oslo University Hospital
Eivind Hovig
Eivind Hovig University of Oslo
Ola Myklebost
Ola Myklebost University of Bergen
Jingfang Ju
Jingfang Ju Stony Brook University
Wen Guo Jiang
Wen Guo Jiang Cardiff University
Leonardo A. Meza-Zepeda
Leonardo A. Meza-Zepeda Oslo University Hospital
Ben Davidson
Ben Davidson Oslo University Hospital
Lewis K. Pannell
Lewis K. Pannell National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn't always mean attending traditional, on-campus programs. Today, there are numerous most affordable accredited online rn to bsn programs available for registered nurses (RNs) aiming to earn a Bachelor of Science in Nursing (BSN) while balancing work and personal commitments.

For those with a passion for advanced practice or research, exploring a phd in nursing can open doors to academic, clinical, and leadership positions. These programs are designed for nurses seeking to deepen their expertise.

Non-nurses who wish to make a swift career change into nursing may consider direct entry nurse practitioner programs for non-nurses online. These programs provide an accelerated path to becoming a nurse practitioner, even for those without a prior nursing background.

If you're just starting out and looking for accessible options, some of the direct entry nursing programs offer less competitive admissions and flexible study schedules, making it easier to begin your nursing education journey.

Best Scientists Citing Øystein Fodstad

Trending Scientists

Recently Published Articles